K142042 is an FDA 510(k) clearance for the ERCHONIA SHL. Classified as Fat Reducing Low Level Laser within the OLI classification (a category for non-invasive low-level laser body contouring systems), Class II - Special Controls.
Submitted by Erchonia Corporation (Littleton, US). The FDA issued a Cleared decision on October 21, 2014 after a review of 85 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.5400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Erchonia Corporation devices
NCT01821352
Completed
Interventional
Industry-sponsored
Study of Low Level Laser Therapy to Reduce Body Circumference in Obese Individuals
A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia Obesity Laser on the Reduction of Circumference of the Hips, Waist and Upper Abdomen for Individuals With a Body Mass Index (BMI) of 30 to 40 kg/m2
| Condition studied |
Obesity |
| Study design |
Parallel |
| Eligibility |
All sexes
· 18 Years+
· Healthy volunteers accepted
|
| Principal investigator |
Steven Shanks |
| Sponsor |
Erchonia Corporation
(industry)
|
Started 2013-03-01
→
Primary completion 2014-04-01
Primary outcome
Difference in the Proportion of Primary Outcome Successes Between Treatment Groups for Change in Combined Circumference Measurements
View full study on ClinicalTrials.gov